Ben Teply, MD

Assistant Professor

  • 3334 Citations
  • 11 h-Index
20042019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ben Teply is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Castration Medicine & Life Sciences
Nanoparticles Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Insulin Engineering & Materials Science
Ferrosoferric Oxide Chemical Compounds
Androgens Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU-AA-302

Teply, B. A., Qiu, F., Antonarakis, E. S., Carducci, M. A. & Denmeade, S. R., Jun 1 2019, In : Prostate. 79, 8, p. 929-933 5 p.

Research output: Contribution to journalArticle

Placebos
Neoplasm Metastasis
Prednisone
Prostatic Neoplasms
Confidence Intervals
29 Citations (Scopus)

Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study

Teply, B. A., Wang, H., Luber, B., Sullivan, R., Rifkind, I., Bruns, A., Spitz, A., DeCarli, M., Sinibaldi, V., Pratz, C. F., Lu, C., Silberstein, J. L., Luo, J., Schweizer, M. T., Drake, C. G., Carducci, M. A., Paller, C. J., Antonarakis, E. S., Eisenberger, M. A. & Denmeade, S. R., Jan 2018, In : The Lancet Oncology. 19, 1, p. 76-86 11 p.

Research output: Contribution to journalArticle

Castration
Androgens
Prostatic Neoplasms
Therapeutics
MDV 3100
11 Citations (Scopus)

Extreme Response to High-dose Testosterone in BRCA2- and ATM-mutated Prostate Cancer

Teply, B. A., Kachhap, S., Eisenberger, M. A. & Denmeade, S. R., Mar 1 2017, In : European Urology. 71, 3, 1 p.

Research output: Contribution to journalLetter

Testosterone
Prostatic Neoplasms
13 Citations (Scopus)

Treatment strategies for DNA repair-deficient prostate cancer

Teply, B. A. & Antonarakis, E. S., Aug 3 2017, In : Expert Review of Clinical Pharmacology. 10, 8, p. 889-898 10 p.

Research output: Contribution to journalReview article

DNA Repair-Deficiency Disorders
Prostatic Neoplasms
DNA Repair
Neoplasms
Therapeutics
9 Citations (Scopus)

Chemotherapy options in castration-resistant prostate cancer

Teply, B. A. & Hauke, R. J., Oct 1 2016, In : Indian Journal of Urology. 32, 4, p. 262-270 9 p.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Drug Therapy
docetaxel
Circulating Neoplastic Cells